RIVM will calculate temporary background value for PFAS in soil In the coming weeks, RIVM will derive a temporary background value for PFAS in Dutch soil. This will be done based on measurement data from the provinces in the Netherlands.
RIVM reaction to farmers protest on 16 October 2019 On 16 October, farmers protested in the vicinity of RIVM in Bilthoven. The Director-General of RIVM, Hans Brug, was present at the protest site.
Openness about nitrogen There is concern about the current approach to nitrogen and the proposed measures; these concerns have been expressed in Dutch society as a whole and amongst farmers in particular.
Cold meat cuts probable source of 20 listeria cases RIVM has identified a cluster of 20 patients diagnosed with listeria over the past 2 years who are most likely to have been infected with an identical strain.
Summary International Expert Meeting on breast implant-associated lymphoma On November 19th 2018, RIVM organised an international expert meeting on a rare type of lymphoma that is associated with breast implants.
No decline in CO2 emissions since 1990 Dutch greenhouse gas emissions were 13 per cent lower in 2017 than in 1990. Emissions have been almost constant over the past five years.
RIVM will make measurements around the Sint Maarten landfill From 21 January 2019, a team from RIVM will travel to Sint Maarten to make measurements and take samples at various locations around the landfill in Philipsburg.
Explanation for difference in development ammonia emissions and concentrations Since 2005, higher ammonia concentrations have been measured in the air, despite registered emissions decreasing. New RIVM research shows that three-quarters of this difference can be explained by changes in atmospheric and chemical processes.
Research: HPV vaccine is safe RIVM research shows no causal link between the vaccine against cervical cancer (HPV) and long-term fatigue symptoms in girls.
Teen vaccination against meningococcal disease starts From mid-September, young people born between 1 May and 31 December 2004 will receive an invitation for a vaccination against meningococcal disease.